Post by Amgen

Name: How many patients in your state discontinue GLP-1-based injectable therapies? The answer may be more
Uploaded: 2026-06-05T14:42:04.513Z
Channel: Amgen
Description: How many patients in your state discontinue GLP-1-based injectable therapies? The answer may be more than you think. Visit the Amgen booth #1733 at the American Diabetes Association’s #ADASciSession

1,761,898 followers

How many patients in your state discontinue GLP-1-based injectable therapies? The answer may be more than you think. Visit the Amgen booth #1733 at the American Diabetes Association’s #ADASciSessions to see what this looks like where you practice. Learn more about the often-unseen realities of the obesity patient experience. Not at ADA? Explore the gaps in obesity care here: https://amgen.ly/3QjL8Qh

Video Content